Your browser doesn't support javascript.
loading
Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses.
Hamdan, Firas; Feodoroff, Michaela; Russo, Salvatore; Fusciello, Manlio; Feola, Sara; Chiaro, Jacopo; Antignani, Gabriella; Greco, Francesca; Leusen, Jeanette; Ylösmäki, Erkko; Grönholm, Mikaela; Cerullo, Vincenzo.
Afiliação
  • Hamdan F; Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Feodoroff M; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
  • Russo S; Drug Delivery, Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Fusciello M; Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Feola S; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
  • Chiaro J; Drug Delivery, Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Antignani G; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Greco F; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Leusen J; Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Ylösmäki E; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland.
  • Grönholm M; Drug Delivery, Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Cerullo V; Laboratory of Immunovirotherapy, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Mol Ther Oncolytics ; 28: 264-276, 2023 Mar 16.
Article em En | MEDLINE | ID: mdl-36911070
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia